Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT00596934 · COMPLETED

Trial details

NCT number: NCT00596934
Sponsor: Elif Oral
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fatty Liver Disease, Nonalcoholic

Start date: 2006-02-01
Primary completion: 2009-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.